Related Experiment Video
Updated: Jun 25, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Disseminated intravascular coagulation and purpura fulminans secondary to infection
S N Faust1, R S Heyderman, M Levin
1Department of Paediatrics, Imperial College School of Medicine at St Mary's, Norfolk Place, London, W2 1PG, UK.
Insights
Infection frequently triggers disseminated intravascular coagulation (DIC), a complex blood clotting disorder. This chapter details DIC's cellular and molecular basis and explores current and novel treatment strategies.
Area of Science:
- Hematology
- Pathophysiology
- Infectious Disease
Background:
- Disseminated intravascular coagulation (DIC) is a critical condition often initiated by infections.
- It arises from dysregulation of the body's blood clotting mechanisms.
- Understanding these imbalances is key to managing DIC.
Purpose of the Study:
- To elucidate the cellular and molecular underpinnings of infection-induced DIC.
- To review established and emerging therapeutic approaches for DIC.
- To provide a comprehensive overview for researchers and clinicians.
Main Methods:
- Review of existing literature on DIC pathogenesis.
- Analysis of cellular signaling pathways involved in coagulation.
- Examination of molecular targets for therapeutic intervention.
Main Results:
- Infections disrupt the balance between procoagulant and anticoagulant factors.
- Specific cellular mediators and molecular pathways are identified as crucial in DIC development.
- Current treatments aim to manage the underlying infection and coagulation abnormalities.
Conclusions:
- Infection-triggered DIC is a complex pathophysiological process.
- Targeting specific cellular and molecular pathways offers potential for improved DIC management.
- Further research into experimental therapies is warranted.
Abstract:
Infection is one of the commonest causes of disseminated intravascular coagulation (DIC). DIC is a complex disorder that results from an imbalance of the pro- and anticoagulant regulatory pathways. This chapter will explain the cellular and molecular basis of the disorder and consider the rationale behind current and experimental treatment strategies.
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Endocarditis II: Clinical Features of Infective Endocarditis
Venous Thrombosis III: Interprofessional Care
Acute Inflammation III: Local and Systemic Effects
Hemorrhagic Stroke ll: Pathophysiology

